Patient Transition: Discussing the Different Options for Patients After Post- Trial or Early Access Programmes
Time: 2:00 pm
day: Conference Day Two
Details:
- Explore strategies for transitioning patients from post-trial or expanded access to regular medical care, including potential hurdles and ideal scenarios
- Discuss the potential outcomes and obligations to patients if a medicine does not get approved after trial participation or expanded access
- Engage in a conversation about the varying obligations and approaches to supporting patients in different access contexts
